Followers | 0 |
Posts | 13277 |
Boards Moderated | 0 |
Alias Born | 05/06/2016 |
Monday, December 05, 2016 1:34:24 PM
I do agree that it seems odd that I can’t find the word "engineered" anywhere associated with Lacto-Freedom.
They do state that a study was done by Celprogen. Unless you can prove that more than one study was done, I’ll assume it was the one done for the bio-engineered bacteria.
I think most physicians would advise quitting one drug before starting another of the same type, unless it was a prescription medication and one was being added to the regimen while the patient was under doctor supervision
With supplements, no medical supervision is required and many people routinely take several, many of which are known to conflict with others. A total of 820 drugs (5704 brand and generic names) are known to interact with St. John's wort. Even grapefruit juice is known to interact with many prescription medications and OTC drugs.
If you were releasing a supplement that contained a special blend of bacteria designed to treat a specific condition, would you want that blend to compete against numerous other unknown strains that the individual may be consuming? Strains which do not offer the same lactose-preventative benefit as the ones in your blend? Seems to me that would be an exercise in futility, like chasing a cholesterol-lowering supplement with a stick of butter.
BTW, the product has 100% 5-star reviews on Amazon.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM